Integer Stock Forecast, Price & News

+3.73 (+4.16 %)
(As of 06/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume210,822 shs
Average Volume150,341 shs
Market Capitalization$3.08 billion
P/E Ratio45.51
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ITGR News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Integer logo

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.49 out of 5 stars

Medical Sector

615th out of 2,100 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

8th out of 42 stocks

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Integer (NYSE:ITGR) Frequently Asked Questions

Is Integer a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Integer stock.
View analyst ratings for Integer
or view top-rated stocks.

What stocks does MarketBeat like better than Integer?

Wall Street analysts have given Integer a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Integer wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Integer's next earnings date?

Integer is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Integer

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) announced its earnings results on Thursday, April, 29th. The medical equipment provider reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.11. The medical equipment provider had revenue of $290.47 million for the quarter, compared to analyst estimates of $283.10 million. Integer had a trailing twelve-month return on equity of 6.66% and a net margin of 6.54%.
View Integer's earnings history

How has Integer's stock been impacted by Coronavirus (COVID-19)?

Integer's stock was trading at $79.33 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ITGR stock has increased by 17.6% and is now trading at $93.29.
View which stocks have been most impacted by COVID-19

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share (EPS) guidance of 3.520-3.900 for the period, compared to the Thomson Reuters consensus estimate of $3.420. The company issued revenue guidance of $1.18 billion-$1.21 billion, compared to the consensus revenue estimate of $1.18 billion.

What price target have analysts set for ITGR?

2 analysts have issued twelve-month target prices for Integer's stock. Their forecasts range from $85.00 to $100.00. On average, they expect Integer's share price to reach $92.50 in the next year. This suggests that the stock has a possible downside of 0.8%.
View analysts' price targets for Integer
or view top-rated stocks among Wall Street analysts.

Who are Integer's key executives?

Integer's management team includes the following people:
  • Mr. Joseph W. Dziedzic, Pres, CEO & Director (Age 53, Pay $1.92M)
  • Mr. Jason K. Garland, Exec. VP & CFO (Age 47, Pay $776.76k)
  • Ms. Jennifer M. Bolt, Sr. VP of Global Operations & ESG (Age 52, Pay $615.83k)
  • Mr. Payman Khales, Pres of Cardio & Vascular (Age 51, Pay $641.39k)
  • Mr. Joel D. Becker, Pres of Cardiac Rhythm Management & Neuromodulation (Age 53, Pay $590.45k)
  • Mr. Anthony W. Borowicz, Sr. VP of Strategy, Corp. Devel. & Investor Relations (Age 64)
  • Ms. Elizabeth K. Giddens, Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. (Age 50)
  • Mr. Kirk K. Thor, Exec. VP & Chief HR Officer (Age 57)
  • Mr. Joseph Flanagan, Exec. VP of Quality & Regulatory Affairs (Age 62)
  • Mr. Carter Houghton, Pres of Electrochem & Power Solutions (Age 52)

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer CEO Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among Integer's employees.

Who are some of Integer's key competitors?

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), The Procter & Gamble (PG), Gilead Sciences (GILD), The Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

What is Integer's stock symbol?

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Who are Integer's major shareholders?

Integer's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.73%), Franklin Resources Inc. (6.52%), Dimensional Fund Advisors LP (5.74%), Hawk Ridge Capital Management LP (2.34%), Standard Life Aberdeen plc (2.31%) and Fisher Asset Management LLC (1.95%). Company insiders that own Integer stock include Bill R Sanford, Jean M Hobby, Joseph W Dziedzic, Pamela G Bailey and Peter H Soderberg.
View institutional ownership trends for Integer

Which institutional investors are selling Integer stock?

ITGR stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Hawk Ridge Capital Management LP, Dalton Greiner Hartman Maher & Co., William Blair Investment Management LLC, Fisher Asset Management LLC, Northern Trust Corp, Man Group plc, and JPMorgan Chase & Co.. Company insiders that have sold Integer company stock in the last year include Bill R Sanford, and Jean M Hobby.
View insider buying and selling activity for Integer
or view top insider-selling stocks.

Which institutional investors are buying Integer stock?

ITGR stock was acquired by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Aureus Asset Management LLC, BlackRock Inc., Chartwell Investment Partners LLC, Congress Asset Management Co. MA, Ameriprise Financial Inc., Tamarack Advisers LP, and Victory Capital Management Inc..
View insider buying and selling activity for Integer
or or view top insider-buying stocks.

How do I buy shares of Integer?

Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integer's stock price today?

One share of ITGR stock can currently be purchased for approximately $93.29.

How much money does Integer make?

Integer has a market capitalization of $3.08 billion and generates $1.07 billion in revenue each year. The medical equipment provider earns $77.26 million in net income (profit) each year or $2.77 on an earnings per share basis.

How many employees does Integer have?

Integer employs 7,500 workers across the globe.

What is Integer's official website?

The official website for Integer is www.integer.net.

Where are Integer's headquarters?

Integer is headquartered at 5830 Granite Parkway Suite 1150, Plano TX, 75024.

How can I contact Integer?

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at 214-618-5243 or via email at [email protected]

This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.